Matches in Nanopublications for { ?s ?p "[Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- assertion description "[Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP678172.RAUeH9jwXApsFdwWUQpoiqbFOH481FicMP1cslZteTDvI130_assertion description "[Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP678172.RAUeH9jwXApsFdwWUQpoiqbFOH481FicMP1cslZteTDvI130_provenance.
- NP680889.RAdbF9E0i_bTn5wJdk54qYIw2-DGJonpFBG1MPTSiJ_DU130_assertion description "[Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP680889.RAdbF9E0i_bTn5wJdk54qYIw2-DGJonpFBG1MPTSiJ_DU130_provenance.
- assertion description "[Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1374014.RATZRiNk8-WjYNectmDtWACf2mlsCXQoiiRXPbr-vlfcs130_assertion description "[Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1374014.RATZRiNk8-WjYNectmDtWACf2mlsCXQoiiRXPbr-vlfcs130_provenance.
- NP1374011.RAgMJQqK6t1pkEdzt4vmEBbp3T1TrK5m81K0X8u2q6im4130_assertion description "[Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1374011.RAgMJQqK6t1pkEdzt4vmEBbp3T1TrK5m81K0X8u2q6im4130_provenance.
- NP1374015.RAidTZChIGfto5AEGI2296vn6hY362e1W8hCl9guhNIik130_assertion description "[Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1374015.RAidTZChIGfto5AEGI2296vn6hY362e1W8hCl9guhNIik130_provenance.
- NP308152.RA4iIrAOvQNedHG1yw0AjhisF-gLDtxvP0P3xIji6dmlY130_assertion description "[Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP308152.RA4iIrAOvQNedHG1yw0AjhisF-gLDtxvP0P3xIji6dmlY130_provenance.
- NP306643.RA3gBTvdsdcEIDoP-tp1r0gcXan8PKAE0YaMcYLQknx-4130_assertion description "[Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306643.RA3gBTvdsdcEIDoP-tp1r0gcXan8PKAE0YaMcYLQknx-4130_provenance.
- NP1374013.RA7uLckKwxE6XxcPj5KvIVkF3TTBlFY3j0xcvpy_DQ3l0130_assertion description "[Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1374013.RA7uLckKwxE6XxcPj5KvIVkF3TTBlFY3j0xcvpy_DQ3l0130_provenance.